Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levo-ornidazole sodium chloride injection for abdominal anaerobic bacterial infection
ChiCTR-TRC-12002067Phase 2Completed
- Sponsor
- Tianjin Fourth Central Hospital
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levornidazole in intra-abdominal bacterial infection (IBI) (2 arms), sponsored by Tianjin Fourth Central Hospital. Primary endpoint: Red blood cells. Started Apr 2011; status: completed.
02
Drugs
levornidazole
03
Conditions
intra-abdominal bacterial infection (IBI)
Beyond the preview
Go deeper on ChiCTR-TRC-12002067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002067.